5–6 décembre 2003
Toulouse, France
Plus d’informations à venir
Liste des communications
Claude Crampes (IDEI and GREMAQ), « The Pricing of Pharmaceuticals Facing Parallel Imports », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
Sara F. Ellison (Massachusetts Institute of Technology), « Countervailing Power in Wholesale Pharmaceuticals », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
Mark Gersovitz (The Johns Hopkins University), « The Economical Control of Infectious Diseases », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
Brigitte Granville (Queen Mary, University of London), « Markets for Pharmaceuticals and Absorptive Capacity in Developing Nations : The Case of Transition Economies », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
William Jack (Georgetown University), « Financing Pharmaceutical Innovation : How Much Should Poor Countries Contribute? », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
Kristina M. Lybecker (Drexel University), « Rx Roulette : Counterfeit Pharmaceuticals in Developing Nations », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
Stéphane Mechoulan (NBER), « Intellectual Property & External Consumption Effects : Generalizations from Pharmaceuticals Markets », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
Alice Mesnard (ARQADE, IDEI, University of Toulouse), « Migration and Quarantine in the Presence of Asymmetric Information about Risk of Infectious Disease », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
Shyama V. Ramani (INRA, Grenoble), « TRIPS and its Possible Impact on the Indian Biopharmaceutical Industry », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
F. M. Scherer (Princeton University), « Global Welfare in Pharmaceutical Patenting », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.
Christopher M. Snyder (George Washington University), « Are Drugs More Profitable than Vaccines? », Markets for Pharmaceuticals and the Health of Developing Nations, Toulouse, France, 5–6 décembre 2003.